How women are transforming life sciences

maureen-ladouceur

Maureen Ladouceur is Norstella’s EVP and Chief Commercial Officer. She recently spoke with Andrea Charles, VP of Custom Content at Norstella, about her career in life sciences, women leading innovation in this space, and what major trends she expects for this industry. Highlights from their discussion are summarized below. A career focused on patient impact […]

GLP-1: The 360° view

GLP-1-weight-loss-drugs-featured-image

The GLP-1 agonist class of drugs, pioneered by Eli Lilly and Novo Nordisk, has become the biggest news story within the biopharma industry of the last couple of years. With tremendous clinical data supporting >20% weight loss and reduction in cardiovascular outcomes, there is seemingly no limit to the potential of these medicines. Analysts and […]

Eight routes to patient diversity

Patient-diversity-hero

Norstella helps clients achieve diversity in clinical trials while committing to it in its own practices. Andrew Warmington, manufacturing editor at Norstella, spoke to Fenwick Eckhardt, senior manager of clinical new product development at Norstella Diversity is a widely used term in many contexts and clinical trials are no exception. But what does the word […]

Our AI capabilities are built to evolve—transforming data into insight, insight into action, and action into impact.